Hypertension and beyond in Indian clinical practice study: a nationwide survey assessing knowledge, attitude and practices of physicians


  • Uday Jadhav Dr Jadhav Cardiac Centre, CBD Belapur, Navi, Mumbai, Maharashtra, India
  • Arun Purohit Purohit Clinic, Sector 14, Gurgaon, Haryana, India




Hypertension, Heart failure, Risk calculator, Fixed-dose combinations, Cardiovascular risk, Decision making


Background: Hypertension is the leading cause for the ever-increasing burden of mortality due to stroke and cardiovascular diseases (CVD). Treatments are complicated due to comorbidities and can lead to patient noncompliance. Patients with low existing cardiovascular risk are prone to have higher lifetime cardiovascular risk, which timely assessment necessary.

Methods: A digital cross-sectional survey questionnaire about knowledge, attitude and practice habits regarding cardiovascular risk assessment was administered to 400 physicians and cardiologists across India. The questionnaire assessed various topics such as practice of hypertension diagnosis and treatment based on guidelines, cardiovascular risk calculators, occurrence of comorbidities and patient awareness on cardiovascular risk prevention.

Results: Out of the 400 physicians, 398 completed the survey. About 52% physicians considered presence of multiple risk factors as vital for having cardiovascular risk. American college of cardiology/American heart association (ACC/AHA) calculator was preferred by 51.6% study participants. Cardiovascular risk estimation was vital for treatment-related decision-making according to 71% participants, while only 7.7% participants calculated cardiovascular risk in >90% of their patients. Approximately 44% survey participants calculated cardiovascular risk in hypertensive patients with 2 additional risk factors, while 5.6% calculated it in >70% hypertensive patients without comorbidities. About 46.6% participants reported that 30%-50% of their patients were on fixed-dose combinations of two antihypertensive medications.

Conclusions: Findings from the study indicate predisposition of medical professionals towards having a risk assessment tool designed for the Indian population to timely assess and forestall long-term effects of cardiovascular risk in hypertensive patients.



Prabhakaran D, Jeemon P, Roy A. Cardiovascular diseases in India: Current epidemiology and future directions. Circulation. 2016;133:1605-20.

Chopra HK, Ram CVS. Recent guidelines for hypertension. Circ Res. 2019;124:984-6.

Anchala R, Kannuri NK, Pant H, Khan H, Franco OH, Di Angelantonio E, et al. Hypertension in India: a systematic review and meta-analysis of prevalence, awareness, and control of hypertension. J Hypertens. 2014;32:1170-7.

Karmakar N, Nag K, Saha I, Parthasarathi R, Patra M, Sinha R. Awareness, treatment, and control of hypertension among adult population in a rural community of Singur block, Hooghly District, West Bengal. J Educ Health Promot. 2018;7:134.

Law TK, Yan AT, Gupta A, Kajil M, Tsigoulis M, Singh N, et al. Primary prevention of cardiovascular disease: global cardiovascular risk assessment and management in clinical practice. Eur Heart J Qual Care Clin Outcomes. 2015;1:31-6.

Standard treatment guidelines on hypertension by Ministry of Health & Family Welfare Government of India. Available at: https://nhm.gov.in/images/pdf/guidelines/nrhm-guidelines/stg/Hypertension_full.pdf. Accessed on 29 December 2020.

Garg N, Muduli SK, Kapoor A, Tewari S, Kumar S, Khanna R, et al. Comparison of different cardiovascular risk score calculators for cardiovascular risk prediction and guideline recommended statin uses. Indian Heart J. 2017;69:458-63.

Bansal M, Mehrotra R, Kasliwal RR. Cardiovascular risk stratification in Indians. J Clin Prev Cardiol. 2015;5:7-17.

Jayagopal PB, Rao MS, Vijayakumar R, Kumar S, Pradhan G. Consensus statement for the management of dyslipidemia and hypertension in the Indian population with diabetes. Int J Adv Med. 2019;6:562-70.

Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Himmelfarb CD, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol. 2018;71:127-248.

Risk estimation and the prevention of cardiovascular disease: A national clinical guideline | Royal College of Physicians of Edinburgh. Available at: https://www.rcpe.ac.uk/college/risk-estimation-and-prevention-cardiovascular-disease-national-clinical-guideline. Accessed on 10 May 2021.

Arya DS, Chowdhury S, Chawla R, Das AK, Ganie MA, Kumar KMP, et al. Clinical benefits of fixed dose combinations translated to improved patient compliance. J Assoc Physicians India. 2019;67:58-64.

Sundström J, Arima H, Woodward M, Jackson R, Karmali K, Lloyd-Jones D, et al. Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data. The Lancet. 2014;384:591-8.

Eaton CB, Galliher JM, McBride PE, Bonham AJ, Kappus JA, Hickner J. Family physician’s knowledge, beliefs, and selfreported practice patterns regarding hyperlipidemia: a National Research Network (NRN) survey. J Am Board Fam Med. 2006;19:46-53.

Oriol-Zerbe C, Abholz HH. Primary prevention of cardiovascular diseases by lipid-lowering treatment in German general practice: results from GPs ignoring guidelines and risk calculators. Eur J Gen Pract. 2007;13:27-34.

Graham IM, Stewart M, Hertog MG; Cardiovascular Round Table Task Force. Factors impeding the implementation of cardiovascular prevention guidelines: findings from a survey conducted by the European Society of Cardiology. Eur J Cardiovasc Prev Rehabil. 2006;13:839-45.

Hobbs FDR, Jukema JW, Da Silva PM, McCormack T, Catapano AL. Barriers to cardiovascular disease risk scoring and primary prevention in Europe. Q J Med. 2010;103:727-39.

James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. Evidence-based guideline for the management of high blood pressure in adults report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507-20.

Gupta CN, Akul SK, Mahapatra S, Lahiri A, Maji K, Sen S. Evaluation of antihypertensive drug prescription patterns, rationality, and adherence to Joint National Committee-8 hypertension treatment guidelines among patients attending medicine OPD in a tertiary care hospital. Int J Cont Med Res. 2019;6:31-7.

Dhar L. Preventing coronary heart disease risk of slum dwelling residents in India. J Family Med Prim Care. 2014;3:58-62.

Van Steenkiste B, van der Weijden T, Stoffers HE, Grol R. Barriers to implementing cardiovascular risk tables in routine general practice. Scand J Prim Health Care. 2004;22:32-7.

Van Steenkiste B, van der Weijden T, Timmermans D, Vaes J, Stoffers J, Grol R. Patients’ ideas, fears and expectations of their coronary risk: barriers for primary prevention. Patient Educ Couns. 2004;55:301-7.






Original Research Articles